Glial cell line-derived neurotrophic factor enhances human islet posttransplantation survival

Transplantation

Volumn 92, Issue 7, 2011, Pages 745-751

  Mwangi, Simon M ^a,b   Usta, Yousef ^a   Shahnavaz, Nikrad ^a   Joseph, Irene ^b   Avila, Jose ^c   Cano, Jose ^c   Chetty, Veerappa K ^d   Larsen, Christian P ^c   Sitaraman, Shanthi V ^a   Srinivasan, Shanthi ^a,b  

^a EMORY UNIVERSITY   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; GDNF; Islet survival; Islet transplantation; Normoglycemia

Indexed keywords

ARGININE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA1; GLUCOSE; INSULIN; PROTEIN KINASE B; PROTEIN RET; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STREPTOZOCIN DIABETES;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLUCOSE; GRAFT SURVIVAL; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, NUDE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; STREPTOZOCIN; TRANSPLANTATION, HETEROLOGOUS;

EID: 80053328827     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31822bc95a     Document Type: Article

References (18)

1. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
3. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginaldose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
4. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037.
5. O'Connell PJ, Hawthorne WJ, Holmes-Walker DJ, et al. Clinical islet transplantation in type 1 diabetes mellitus: Results of Australia's first trial. Med J Aust 2006; 184: 221.
6. Hanson MS, Park EE, Sears ML, et al. A simplified approach to human islet quality assessment. Transplantation 2010; 89: 1178.
7. Anitha M, Gondha C, Sutliff R, et al. GDNF rescues hyperglycemiainduced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest 2006; 116: 344.
8. Scharp DW, Lacy PE, Santiago JV, et al. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 1990; 39: 515.
9. Carter J, Karmiol S, Nagy M, et al. Pretransplant islet culture: A comparison of four serum-free media using a murine model of islet transplantation. Transplant Proc 2005; 37: 3446.
10. Miao G, Mace J, Kirby M, et al. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Transplantation 2006; 81: 519.
11. Park KS, Kim YS, Kim JH, et al. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 2010; 89: 509.
12. Sakuma Y, Ricordi C, Miki A, et al. Effect of pituitary adenylate cyclaseactivating polypeptide in islet transplantation. Transplant Proc 2009; 41: 343.
13. Mwangi S, Anitha M, Mallikarjun C, et al. Glial cell line-derived neurotrophic factor increases beta-cell mass and improves glucose tolerance. Gastroenterology 2008; 134: 727.
14. Young HM, Hearn CJ, Farlie PG, et al. GDNF is a chemoattractant for enteric neural cells. Dev Biol 2001; 229: 503.
15. von Boyen GB, Reinshagen M, Steinkamp M, et al. Enteric nervous plasticity and development: Dependence on neurotrophic factors. J Gastroenterol 2002; 37: 583.
16. Worley DS, Pisano JM, Choi ED, et al. Developmental regulation of GDNF response and receptor expression in the enteric nervous system. Development 2000; 127: 4383.
17. Turgeon NA, Avila JG, Cano JA, et al. Experience with a novel efalizumabbased immunosuppressive regimen to facilitate single donor islet cell transplantation. Am J Transplant 2010; 10: 2082.
18. Mwangi SM, Usta Y, Raja SM, et al. Glial cell line-derived neurotrophic factor enhances neurogenin3 gene expression and beta-cell proliferation in the developing mouse pancreas. Am J Physiol Gastrointest Liver Physiol 2010; 299: G283.